<VariationArchive VariationID="1075580" VariationName="NM_003239.5(TGFB3):c.170dup (p.Pro57_Glu58insTer)" VariationType="Duplication" Accession="VCV001075580" Version="5" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2021-05-10" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1063165" VariationID="1075580">
      <GeneList>
        <Gene Symbol="TGFB3" FullName="transforming growth factor beta 3" GeneID="7043" HGNC_ID="HGNC:11769" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>14q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="75958097" stop="75983011" display_start="75958097" display_stop="75983011" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="76424441" stop="76448091" display_start="76424441" display_stop="76448091" Strand="-" />
          </Location>
          <OMIM>190230</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003239.5(TGFB3):c.170dup (p.Pro57_Glu58insTer)</Name>
      <CanonicalSPDI>NC_000014.9:75980723:GGGGGG:GGGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>14q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="75980723" stop="75980724" display_start="75980723" display_stop="75980724" variantLength="1" positionVCF="75980723" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="76447066" stop="76447067" display_start="76447066" display_stop="76447067" variantLength="1" positionVCF="76447066" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.8" sequenceAccession="NC_000014" sequenceVersion="8" change="g.76447072dup" Assembly="GRCh37">
            <Expression>NC_000014.8:g.76447072dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.9" sequenceAccession="NC_000014" sequenceVersion="9" change="g.75980729dup" Assembly="GRCh38">
            <Expression>NC_000014.9:g.75980729dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011715.1" sequenceAccession="NG_011715" sequenceVersion="1" change="g.6026dup">
            <Expression>NG_011715.1:g.6026dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329938.2" sequenceAccession="NM_001329938" sequenceVersion="2" change="c.170dup">
            <Expression>NM_001329938.2:c.170dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001316867.1" sequenceAccession="NP_001316867" sequenceVersion="1" change="p.Pro57_Glu58insTer">
            <Expression>NP_001316867.1:p.Pro57_Glu58insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001329939.2" sequenceAccession="NM_001329939" sequenceVersion="2" change="c.170dup">
            <Expression>NM_001329939.2:c.170dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001316868.1" sequenceAccession="NP_001316868" sequenceVersion="1" change="p.Pro57_Glu58insTer">
            <Expression>NP_001316868.1:p.Pro57_Glu58insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003239.5" sequenceAccession="NM_003239" sequenceVersion="5" change="c.170dup" MANESelect="true">
            <Expression>NM_003239.5:c.170dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003230.1" sequenceAccession="NP_003230" sequenceVersion="1" change="p.Pro57_Glu58insTer">
            <Expression>NP_003230.1:p.Pro57_Glu58insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_399" sequenceAccession="LRG_399">
            <Expression>LRG_399:g.6026dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2140254449" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003239.5(TGFB3):c.170dup (p.Pro57_Glu58insTer) AND Rienhoff syndrome" Accession="RCV002551569" Version="9">
        <ClassifiedConditionList TraitSetID="12483">
          <ClassifiedCondition DB="MedGen" ID="C3810012">Rienhoff syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-04-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-04-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-05-10" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25835445</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26188975</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31898322</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="12483" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18469" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Rienhoff syndrome</ElementValue>
                <XRef ID="MONDO:0014262" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Loeys-Dietz syndrome 5</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">RNHF</ElementValue>
                <XRef Type="MIM" ID="615582" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">LDS5</ElementValue>
                <XRef Type="MIM" ID="615582" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12356" />
                <XRef ID="12356" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Loeys-Dietz syndrome (LDS) is characterized by vascular findings (cerebral, thoracic, and abdominal arterial aneurysms and/or dissections), skeletal manifestations (pectus excavatum or pectus carinatum, scoliosis, joint laxity, arachnodactyly, talipes equinovarus, cervical spine malformation and/or instability), craniofacial features (widely spaced eyes, strabismus, bifid uvula / cleft palate, and craniosynostosis that can involve any sutures), and cutaneous findings (velvety and translucent skin, easy bruising, and dystrophic scars). Individuals with LDS are predisposed to widespread and aggressive arterial aneurysms and pregnancy-related complications including uterine rupture and death. Individuals with LDS can show a strong predisposition for allergic/inflammatory disease including asthma, eczema, and reactions to food or environmental allergens. There is also an increased incidence of gastrointestinal inflammation including eosinophilic esophagitis and gastritis or inflammatory bowel disease. Wide variation in the distribution and severity of clinical features can be seen in individuals with LDS, even among affected individuals within a family who have the same pathogenic variant.</Attribute>
                <XRef ID="NBK1133" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301312</ID>
                <ID Source="BookShelf">NBK1133</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2020">
                <URL>https://www.nice.org.uk/guidance/ng156</URL>
                <CitationText>UK NICE Guideline NG156, Abdominal aortic aneurysm: diagnosis and management, 2020</CitationText>
              </Citation>
              <XRef ID="C3810012" DB="MedGen" />
              <XRef ID="MONDO:0014262" DB="MONDO" />
              <XRef Type="MIM" ID="615582" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3116147" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="10701165|MedGen:C3810012" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001590476" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25835445</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26188975</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31898322</ID>
          </Citation>
          <Comment>Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This sequence change creates a premature translational stop signal (p.Glu58*) in the TGFB3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TGFB3 are known to be pathogenic (PMID: 25835445, 26188975). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with TGFB3-related conditions (PMID: 31898322). ClinVar contains an entry for this variant (Variation ID: 1075580). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TGFB3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000014.8:g.76447066_76447067insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3810012" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3116147" TraitType="Disease" MappingType="XRef" MappingValue="C3810012" MappingRef="MedGen">
        <MedGen CUI="C3810012" Name="Rienhoff syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

